Blood · 2005 · 131 citations · 15 references
MedicineCardiologyInternal MedicineCardiac TransplantationStem Cell TransplantationTransplant SurgeryAmyloid FormationAutologous Stem Cell TransplantationCell EngraftmentHeart TransplantationTransplant OutcomesTransplant RejectionAutologous Stem Cell InfusionAutologous Stem Cell Therapy
Extensive cardiac amyloid deposition in systemic AL amyloidosis is associated with a grave prognosis. Heart transplantation is rarely performed because of the systemic and progressive nature of the disease. Patients with severe cardiac amyloid infiltration are ineligible for the preferred treatment of melphalan chemotherapy with stem cell transplantation (SCT) rescue because of the high risk for treatment-related mortality. Heart transplantation followed by SCT was performed in 5 patients with AL amyloidosis and predominant cardiomyopathy. Patients were followed up for a median of 95 months (range, 37-118 months) from diagnosis. At censor, 3 of 5 patients were well without evidence of intracardiac or extracardiac amyloid accumulation, and median overall survival by Kaplan-Meier estimate was not reached. Two patients died of progressive amyloidosis 33 and 90 months after heart transplantation after relapse of their underlying plasma cell dyscrasia. Heart transplantation followed by SCT is feasible in selected patients with cardiac AL amyloidosis and may confer substantial survival benefit.
15
Robert A. Kyle, Morie A. Gertz, Philip R. Greipp et al. · New England Journal of Medicine · 1997 · 691 citations · Full text
Helen J. Lachmann, R Gallimore, Julian D. Gillmore et al. · British Journal of Haematology · 2003 · 433 citations · Full text
Martha Skinner, Jennifer J. Anderson, Robert W. Simms et al. · The American Journal of Medicine · 1996 · 372 citations